Skip to content
naulon
Not checkedNot checked for notices yet.

The relationship

Ahmad Mahran

Middle East Fertility Society Journal · 2016

doi:10.1016/j.mefs.2015.06.003 (opens in a new tab)

We email you when a new notice or a question about this paper appears.

Abstract

Anti-müllerian hormone (AMH) is a dimeric glycoprotein, which is secreted exclusively by granulose cells of primary, preantral, and small antral follicles (4–6 mm). Women with polycystic ovary syndrome (PCOS) have a 2- to 3-fold increase in the serum AMH concentration, which corresponds to the 2- to 3-fold increase in the number of small follicles seen in PCOS. The aim of this study was to assess the relationship between AMH and the clinical, biochemical and sonographic parameters in women with PCOS. In this prospective observational study, serum AMH was measured in 200 PCOS women attending 2 fertility clinics in Minia, Egypt. The relationship between AMH and the clinical, biochemical and sonographic parameters of PCOS was studied. AMH levels were found to have significant positive correlation with cycle length (r = 0.706, P < 0.01), modified Ferriman Gallwey (FG) score for hirsutism (r = 0.329, P < 0.01), mean ovarian volume (r = 0.498, P < 0.01), antral follicle count (AFC) (r = 0.963, P < 0.01) and total testosterone (r = 0.272, P < 0.01). In conclusion, AMH is strongly correlated with the clinical, biochemical and sonographic features of PCOS.

Abstract licence: CC BY-NC-ND

References24

    24 more references, whose wording the paper’s licence keeps private.

    Reads

    Read by people on this page

    None yet.

    Checked or read by AI through naulon

    None yet.

    A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

    Are you an author?

    Is this your paper?

    Claim it to add your note and be paid when agents cite it. Free.